Translating Cancer Molecular Variability into Personalized Information Using Bulk and Single Cell Approaches

Area of Science:

• Oncology and Molecular Biology
• Genomics and Bioinformatics

Background:

• Tumor heterogeneity significantly impedes effective personalized cancer drug selection.
• Current therapies often fail due to patient-specific molecular differences and unaddressed tumor subpopulations.
• Predicting patient response to specific treatments remains a significant clinical challenge.

Purpose of the Study:

• To review bulk and single-cell analysis approaches in cancer research.
• To discuss their application in designing individualized drug therapies.
• To highlight the advantages and limitations of these methods in personalized medicine.

Main Methods:

• Review of current literature on bulk and single-cell analysis techniques.
• Discussion of data analysis tools for large-scale cancer datasets.
• Examination of technological advancements in molecular profiling.

Main Results:

• Bulk and single-cell analyses offer potential for extracting individualized signals from heterogeneous tumor data.
• These approaches are crucial for understanding molecular aberrations driving differential therapy responses.
• Despite advancements, effective personalized therapies remain limited.

Conclusions:

• Bulk and single-cell analyses are pivotal for advancing personalized cancer medicine.
• Addressing tumor heterogeneity is key to developing more efficient patient-specific treatment strategies.
• Further research is needed to overcome limitations and fully realize the potential of individualized drug design.